NCT03202511View on ClinicalTrials.gov

"Assessment of a New Boosting Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers"

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 23, 2017

Primary Completion Date

July 2, 2018

Study Completion Date

July 2, 2018

Conditions
Pre-Exposure Prophylaxis
Interventions
DRUG

Probenecid Oral Tablet

Included in arm/group descriptions.

DRUG

Tenofovir disoproxil fumarate/Emtricitabine

Included in arm/group descriptions.

Trial Locations (1)

46202

Indiana University Clinical Research Center at University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03202511 - "Assessment of a New Boosting Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers" | Biotech Hunter | Biotech Hunter